Nabil Ismaili

8PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 05, 2026
Biomarker-Guided Adjuvant Therapy in Stage II/III Colon Cancer: A Systematic Review of Current Evidence and Clinical Implications.

|May 26, 2026
Total Neoadjuvant Therapy, Organ Preservation and Beyond: A State-of-the-Art Systematic Review and Critical Appraisal of Locally Advanced Rectal Cancer Management.

|Apr 10, 2026
Practice-Changing Trials in Gastrointestinal Cancers at ASCO 2025: A Critical Review and Clinical Context.

Nabil Ismaili

|Feb 27, 2026
A Systematic Review of Major Advances in Breast Cancer Therapeutics in 2025: Synthesis of Conference and Published Evidence.

Nabil Ismaili

|Feb 27, 2026
Major Advances in Gynecologic Oncology in 2025: Systematic Review and Synthesis of Conference and Published Evidence.

Nabil Ismaili

|Sep 09, 2020
COVID-19 and Gynecological Cancers: A Summary of International Recommendations.

Nabil Ismaili, Sanaa Elmajjaoui

Pageof 2

Frequent Collaborators

1 joint publications

Sanaa El Majjaoui